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Living unrelated donor kidney transplantation. survival rates were attributed to the fact that kidneys
Background. Living unrelated donors remain an underuti- from living donors were uniformly healthy.
lized resource, despite their high graft survival rates. In this
Even then, evidence of unexpectedly high graft sur-article, we updated the long-term results of more than 2500
vival rates in living unrelated donor transplants had beenliving unrelated donor transplants performed in the United
States. mounting for years [2–8]. For example, two Korean cen-
Methods. Between 1987 and 1998, 1765 spouse, 986 living ters with the largest numbers of such cases at the time
unrelated, 27,535 living related, and 86,953 cadaver donor
reported that their five-year graft survival rates for livinggrafts were reported to the United Network for Organ Sharing
unrelated donor transplants were near 80%, indistin-Kidney Registry. Kaplan–Meier curves compared graft survival
rates in stratified analyses, and a log-linear analysis adjusted guishable from their living related donor counterparts
donor-specific outcomes for the effects of 24 other transplant [3, 7]. Brain death was not legally accepted in Korea, sofactors.
except for a few non–heart-beating cadaver donor cases,Results. The long-term survival rates for both spouse and
living unrelated transplants were essentially the same (5-year spouses and other living unrelated individuals were the
graft survivals of 75 and 72% and half-lives of 14 and 13 years, only organ source when relatives were unavailable. In
respectively). The results were similar to that for parent donor
countries that have established brain death laws, the acutegrafts (5-year graft survival 5 74% and half-life 5 12 years)
shortage of cadaveric organs has spurred the growth ofand were significantly (P 5 0.003) better than cadaver donor
grafts (5-year graft survival 5 62% and half-life 5 9 years). living unrelated kidney transplants as well.
After adjusting for the presence of transplant factors known Despite the evidence for excellent outcomes, living
to influence survival rates, recipients of living unrelated donor
unrelated donors remain an underutilized resource. Inkidney transplants still had superior outcomes compared with
particular, only a small fraction of the estimated 6000cadaver transplants.
Conclusions. Living unrelated kidney donors represent the potential spouse donors per year have been actual do-
fastest growing donor source in the United States and provide nors in the United States [1, 9]. Besides issues of coer-excellent long-term results. Encouraging spouses to donate
cion, morbidity, and mortality [10], another impedimentcould remove nearly 15% of the patients from the UNOS
waiting list, effectively increasing the number of available ca- to living unrelated donation has been the argument that
daveric organs. less restrictive recipient selection criteria coupled with
greater HLA incompatibility would result in lower suc-
cess rates [11]. In contrast, each successive summary has
Five years ago, we summarized data on kidney grafts shown one-year graft survival rates holding at 90% as
from spouses and other living unrelated donors into pa-
reviewed by Cecka [12].
tients with end-stage renal disease, as reported to the
In this article, we re-examined the results of livingUnited Network for Organ Sharing (UNOS) Transplant
unrelated donor kidney transplants performed in theRegistry [1]. Despite poor human lymphocyte antigen
United States and concentrated on long-term and joint(HLA) matching, these unrelated donor transplants ex-
(that is, combinations of transplant factors) outcomes,hibited high graft and patient survival rates similar to
presenting results of more than 2500 living unrelatedoutcomes of parent donor kidney grafts and superior to
donor transplants reported to the UNOS Kidney Regis-outcomes of cadaver donor kidney grafts. The excellent
try through 1998. Graft survival at five years after trans-
plantation (five-year GS) and graft half-lives (HL; times
Key words: graft survival, end-stage renal disease, organ sharing, renal
in years at which one half of grafts surviving beyond 1transplantation.
year fail) were used as long-term measures. Overall, the
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Table 1. Numeric scores (w) for adjusting graft survival probabilitiesMETHODS
according to type of donor
Study population and variable selection
Categories 1-year 5-year
Between October 1987 and December 1998, data on
Parent 0.2544 20.2786
117,239 renal transplants from 244 centers were reported Sibling 0.2918 0.2350
Other related 20.2002 0.2056to the UNOS Transplant Registry with follow-up through
Spouse 0.0158 20.0214October 1999. Grafts from 1765 spouses, 986 other living
Living unrelated 0.2314 0.1604
unrelated donors, 6855 parents, 4859 HLA-identical sib- Cadaver 20.5934 20.3008
lings, 8787 other siblings, plus 7034 other living related,
and 86,953 cadaver donors were included for study. In
a secondary analysis of adjusted donor-relationship out-
comes among adult ($21-year-old) recipients, it was nec-
essary to partition post-transplant time into consecutive
intervals and to analyze subsets of patients entering each
interval. The initial subset included 98,652 adult trans-
plants that functioned beyond hospital discharge, and
the second set consisted of 87,981 grafts that functioned
beyond one year.
Survival time and indicators for one-year and five-year
graft function, as well as the graft’s function status at the
patient’s last follow-up time were analyzed as outcome
variables. When necessary, the last reported serum creat-
inine value was used to impute one- and five-year graft
function for censored patients [13, 14]. Indicators for the
donor’s relationship to the recipient as well as 24 other
transplant factors (Appendix) were selected as explana-
tory variables for stratification and multivariable analy-
sis. Less than 5% of values were missing for any covari-
ate. When missing, data were replaced with mode values
for categorical variables and mean values for continuous
variables. Continuous variables were further categorized
to obviate linearity assumptions. Fig. 1. Growing use of spouse (d) and other living unrelated (h)
kidney donors at United States transplant centers.
Statistical methods
Kaplan–Meier curves and log-rank tests were used to
describe and compare the graft survival rates in stratified 1.2425 (corresponding to 77.6% graft survival at five
univariate analyses. All P values were two sided. Patients years given 1-year survival), and w is the score corre-
who died were considered to have had graft failure. sponding to the categories and terms outlined in Table 1.
Long-term survival rates were re-expressed as graft HLs, The adjusted values represent the survival that would
that is, times in years at which one half of grafts surviving result if only donor relationship was operational and all
beyond one-year post-transplantation fail [15]. other factors were assumed to be fixed with no variation.
A secondary analysis (used to adjust donor-relation- Overall, the donor relationship accounted for 26 and 4%
ship effects for other transplant factors) was based on a of the variation in one- and five-year outcomes, respec-
method pioneered by Mickey [16, 17]. Donor scores were tively. In this part of the analysis, tests of significance
estimated using a log-linear analysis of partial associa- were done using the chi-square method.
tions of outcome, and reiterated on each post-transplant
period [18]. (The partial associations of outcome were
RESULTSbased on scores from the cofactors and centers given
in Appendix. Readers interested in the details should Spouse and other living unrelated donor grafts have
contact the authors.) Adjusted probabilities of graft sur- increased significantly since 1994 (Fig. 1). After 1995,
vival for different donor sources were estimated ac- the numbers of spouse transplants rose by nearly 20%
cording to the formula: p 5 1/(1 1 exp(2(w0 1 w))), each year so that in 1998 alone, nearly 400 spouse trans-
where exp() denotes the exponential function e; w0 repre- plants were reported to UNOS. During this period, the
sents baseline values 2.1218 (corresponding to 89.3% numbers of other living unrelated donor transplants ap-
peared to stabilize at around 160 per year.graft survival at one year given hospital discharge) and
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Fig. 2. Graft survival rates for kidney transplants performed between
October 1987 and December 1998 according to the donor source. Fig. 3. Annual percentage of U.S. transplant centers reporting at least
one living unrelated donor transplant during each year.
Grafts from HLA-identical siblings (genetically matched
the high survival rates of living unrelated kidney trans-for all of the HLA loci) and from other siblings (with
plants.2.7 average mismatched antigens at the HLA-A, -B, and
The results of secondary analyses adjusting the donor--DR loci) had the highest survival rates (five-year GS 5
relationship survival rates for the effects of center and86 and 75%, and HL 5 22 and 14 years, respectively; Fig.
24 transplant factors are shown in Figure 4. (Note that2). Grafts from cadaver donors (3.4 average mismatched
since the rates were adjusted for the inherent grades ofHLA antigens) had the lowest survival rates (five-year
HLA match as part of the multifactor analysis, all donorGS 5 62% and HL 5 9 years), and grafts from parent
types, including sibling donors, were displayed using onedonors (one HLA-haplotype matched) had intermediate
category per donor type.) Figure 4A depicts the probabil-survival rates (five-year GS 5 74% and HL 5 12 years).
ity of grafts surviving to one year after transplantationThe survival rates for both spouse and other living unre-
given that the recipient was discharged from the hospital,lated transplants were essentially the same (five-year GS
and the right panel shows the survival probabilities toof 75 and 72%, and HL of 14 and 13 years, respectively,
five years provided the recipient had a functioning graftP 5 0.33) and similar to that for parent-donor grafts.
at one year. Bars represent 95% confidence intervals forLiving unrelated donor grafts exhibited significantly bet-
donor-specific categorical rates. All recipients of livingter outcomes (P 5 0.003) than cadaver donor grafts,
donor transplants enjoyed superior one-year graft sur-despite the fact that they had a higher average number
vival rates compared with cadaveric transplants (82%),of mismatched HLA antigens (4.2 mismatches).
and the adjusted one-year graft survival rates for spouseThe number of U.S. centers performing living unre-
(90%) and living unrelated transplants (91%) were simi-lated transplants each year has also steadily increased
lar to rates for living related donor transplants (92% forover the ten year period of this study (Fig. 3). Prior to
parent and sibling donor grafts).1992, fewer than 20% of all UNOS centers reported any
At five years (Fig. 4B), survival rates for patients re-kidney transplants with living unrelated donors. More
ceiving sibling, spouse, or living unrelated donor kidneysrecently (1996 to 1998), nearly 60% (146 of the 244
were approximately equal (approximately 80%) andcenters) of UNOS centers were transplanting kidneys
were well above those for parent and cadaver donorfrom living unrelated donors. Most (140) centers trans-
types that yielded equally poor long-term values (ap-planted between 10 and 30 living unrelated grafts. Over
the course of the study, only 31 of the 244 centers re- proximately 72%). The multifactorial analyses demon-
strated that spouse and living unrelated donor kidneyported no transplants from living unrelated donors. This
fact and the results of the multifactor analysis (Fig. 4) transplants generally had superior short- and long-term
outcomes, regardless of the presence of other transplantconfirm that center-specific effects did not account for
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Fig. 4. Adjusted one- (A) and five (B)-year
graft survival rates according to donor source
(the text discussed the details of the methods;
P , 0.0001).
Fig. 5. Graft survival of wife-to-husband and
husband-to-wife kidney transplants (A; P ,
0.050) and husband-to-wife transplants ac-
cording to the wife’s history of pregnancies
(B; P , 0.094).
factors known to influence survival rates. Specific data, 5, the graft survival rates among wives who received
their husbands kidney were similar (P 5 0.94) to thosepresented next, confirmed this observation by comparing
outcomes for living unrelated donor transplants stratified of wife-to-husband transplants, regardless of the number
of past pregnancies. Thus, even multiparous wives exhib-by several covariates (recipient’s sex, sensitization, and
number of HLA mismatches). ited survival rates exceeding the rates for cadaveric renal
transplants.Regarding the spouse’s relationship, graft survival
rates were not significantly different (P 5 0.50) when The effects of sensitization variables on all (spouses
plus other) living unrelated donor kidney transplantscomparing wife-to-husband or husband-to-wife combi-
nations (Fig. 5), but twice as many wives as husbands were compared and contrasted with effects on cadaver
grafts in Figure 6. The graft survival rate of repeat trans-were donors. Some husbands may have been excluded
as donors by a positive cross-match test since wives may plants from living unrelated donors was significantly (Fig.
6A; P , 0.0001) lower than the rate in primary livinghave been immunized to their husband’s HLA antigens
by pregnancy. However, as shown at the right in Figure unrelated donor grafts (five-year GS of 75 vs. 64% and
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Fig. 6. Comparison of living unrelated and cadaver donor transplants when the recipient may have been immunized by a previous transplant
failure (A), pretransplant blood transfusions (B), or had panel-reactive antibodies (C ).
HL of 14 vs. 8 for first vs. repeat grafts, respectively). survival rates of even the poorest HLA-mismatched cate-
gory (5 to 6 mismatches) of living unrelated transplantsThe magnitudes of the difference in rates between first
and repeat living unrelated donor kidney transplants were better than rates for cadaver transplants with all
levels of HLA mismatch except perfectly matched cases,were greater than corresponding differences found in
cadaver donor transplants. Likewise, the effects of pre- where rates were equal.
The effects of donor type (living unrelated vs. cadaver)transplant transfusions and anti-HLA antibodies (Fig. 6
B and C) were more pronounced (but statistically less and HLA mismatch on delayed graft function (defined as
the percentage of hospital-discharged recipients whosesignificant because of the smaller number of cases)
among living unrelated transplants than cadaver trans- grafts were first-day anuric or who required supplemen-
tal dialysis during the first-week post-transplant) andplants. In both living unrelated and cadaver donor kidney
transplants, patients with six or more transfusions or first-year rejection episodes are shown in Figure 7B. On
average, 7% of living unrelated donor grafts and 24%high levels of panel reactive antibodies (PRA . 50%)
demonstrated poorer long-term outcomes compared of cadaveric grafts exhibited delayed graft function (P ,
0.0001). Modest increases in the percents of delayed graftwith recipients with few transfusions (0 to 5) or low PRA
(0 to 50%). The vast majority of living unrelated donor function among cadaver (a 3% point increase that was
highly statistically significant owing to the large numberkidneys were transplanted to primary (93%) and unsen-
sitized (97%) recipients, indicative of careful selection of cases) and living unrelated (a nonsignificant 7% point
increase) donor transplants were associated with zeroand screening processes.
Increasing numbers of HLA-A, -B, and -DR loci mis- versus some HLA mismatches. Finally, increasing num-
bers of HLA mismatches significantly (P 5 0.001) raisedmatches did not significantly (P 5 0.50) lower graft sur-
vival rates among living unrelated donor kidney trans- the chance of first-year rejection episodes in living unre-
lated transplants. From 0 to 6 HLA mismatches, first-plant recipients (Fig. 7A). There was a tendency for
well-matched living unrelated donor kidney transplants year rejection episodes increased steadily from 11 to
35% in living unrelated donor kidney transplants. Thisto have better survival, but because of small numbers of
such cases, no ordered trends were apparent such as the approximately 20% point increase was similar to the rate
of increase of rejection seen in cadaver donor trans-highly significant (P , 0.0001) hierarchical effects of
HLA found among cadaver transplants. However, the plants.
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Fig. 7. Effect of HLA mismatches on graft survival (A) and delayed graft function and rejection (B) of living unrelated (LUR) and cadaver (Cad)
donor kidney transplants. Note that only 9% of living unrelated donor transplants had fewer than 3 HLA-A, -B, -DR antigens mismatched
compared with 24% of cadaver donor grafts, indicating no selection of living unrelated donors according to HLA compatibility.
DISCUSSION zant of the potential risks of the donor surgery, many
of the studies that identified these levels of risk includeThe transplant literature remains overwhelmingly pos-
very historical cases. More recent evaluations suggestitive regarding the use of living kidney donors. As illus-
that the risks today are probably much lower [29, 31].trated in Figures 1 and 4, the first choice for a living
There is no evidence that living unrelated and relateddonor is still the patient’s sibling and, preferably, an
donors experience different risks.HLA-identical sibling. When siblings and other histo-
The current results from more than 200 U.S. transplantcompatible related donors are not available, kidneys
centers demonstrate that kidney grafts from living unre-from living unrelated donors provide a viable alternative.
lated donors continue to have excellent long-term sur-
Worldwide, recent single-center studies have noted high
vival rates despite a high degree of HLA incompatibility
graft survival rates for recipients of living unrelated do- and that this result is independent of the effects of other
nor kidneys coupled with very low mortality and morbid- transplantation factors (Fig. 4). After adjusting for the
ity rates for the donors themselves [19–27]. For example, effects of center and 24 transplant factors, living unre-
the University of Wisconsin reported five- and ten-year lated donors exhibited short- and long-term graft out-
graft survival rates of 82 and 56%, respectively, in their comes similar to values of sibling donor transplants. At
series of 150 unrelated donor transplants dating back to one-year post-transplantation, all living donor types ex-
1981 [19]. In their long-term experience, only one donor hibited significantly improved adjusted graft survival
died from causes unrelated to the donation, and 17% of rates compared with cadaveric kidney transplants; how-
681 living donors developed postoperative complica- ever, the five-year gs of living unrelated and sibling donor
tions. The risk of death after donor nephrectomy has transplants continued to be good, but the parent donor
been estimated to be 0.03% [28], and the risk of major recipients fared much worse and, in fact, had long-term
complications has been calculated to be 0.23% [29]. The survival rates similar to cadaver kidney recipients. A full
most frequent (.1%) complications have been pneumo- explanation for the poor survival of parental transplants
nia, atelectasis, infection (urinary tract and wound), and is wanting. We suggest that as a consequence of selecting
only adult recipients for the multifactorial study, thepneumothorax [30]. Although it is important to be cogni-
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parent donors were uniformly older (70% . age 50 and the current rate of 374 spouse transplants per year
fall far short of this potential.years), and therefore, their results remained confounded
Aside from the risks of surgery, the donation processby the known detrimental effects of old age despite a
itself may discourage some potential donors who woulddonor age adjustment.
experience economic hardships as a result of the signifi-There was no indication that HLA compatibility
cant recovery time from the donor surgery. UNOS re-played a role in selecting unrelated donor-recipient pairs.
cently authorized employees up to four weeks of paidHowever, the data suggest that recipients of living unre-
leave to cover an absence that results from organ dona-lated donor transplants have been carefully selected be-
tion, a move designed to reduce any economic disincen-cause few were sensitized or retransplanted. Whether
tive to donation. U.S. government employees will receivethis represents a deliberate avoidance of patients with
a similar benefit based on the Organ Donor Leave Act,established immune risk factors or reflects the stringent
which was signed into law in September 1999. The grow-use of sensitive crossmatch tests or both is not clear. The
ing use of laparoscopic surgery for the donor nephrec-presence of immunizing factors (for example, more HLA
tomy also promises to reduce substantially the donors’mismatches, repeat transplantations, transfusions, and
recovery times [32], providing a more rapid return tohigh levels of antibody) lowered survival rates for living
normal activities.unrelated donor kidney grafts, but the short- and long-
However, impediments also seem to be raised by theterm graft survival rates were still better than or equal
medical community fearing inferior outcome and possi-to those for cadaver transplants in patients without im-
ble circumstances of coercion more often than from pa-munizing factors (Figs. 6 and 7).
tients or their families. One survey showed that moreThe stratified analysis measuring the effects of HLA
than 99% of spouse donors would advise other spousesmismatches on living unrelated donor kidney grafts
to donate, and, in general, 82 to 96% of living donors(Fig. 7) did not support the suggestion by Opelz that the
said they would do it again if they could [9, 31, 33]. Thetransplantation of kidneys from unrelated live donors
fact that the donor reaps benefits as well as the recipientshould be done more selectively so that poor HLA
should make spouses the first consideration for kidneymatches can be avoided [11]. In this study, recipients of
donation.living unrelated donor kidneys with five to six HLA
mismatches had success rates equal to recipients of ca- Reprint requests to David W. Gjertson, Ph.D., UCLA Immunogenet-
ics Center, 950 Veteran Avenue, Los Angeles, California 90095, USA.daver kidneys with no HLA mismatches. Our results
E-mail: gjertson@ucla.edusupport the notion that kidneys from living donors are
Appendix. The levels and the computed numerical scores of therelatively undamaged compared with cadaver donor
transplantation factors used in the multivariablegrafts whose nephron function has been compromised
analyses shown in Figure 4
by processes associated with death [1]. In our previous
Factor 1-year 5-yearstudy, when cadaver donor transplants were stratified by
1. Center average 1.0524 0.8475the presence and absence of delayed graft function (a
2. Number of previous transplantssurrogate marker of nephron damage), those “absent” 0 0.1848 0.0614
cases survived long-term with rates comparable to living 1 0.0468 0.0452
.1 20.2316 20.1066donor transplants [1]. In our current study, living unre-
3. Recipient sex
lated grafts exhibited very low rates of delayed graft Male 20.0614 20.1838
Female 0.0614 0.1838function (7%) compared with cadaveric transplants
4. Recipient race(24%), regardless of histocompatibility (Fig. 7).
Caucasian 20.1674 20.0100
Notwithstanding the excellent results, living unrelated Black 20.2652 20.6120
Asian 0.3588 0.3896donors, particularly spouses, have not reached their full
Other 0.0736 0.2324potential as a resource. Among 43,000 patients waiting 5. Recipient age years
for a kidney transplant in the United States, as many as 21–25 0.1288 20.2162
26–45 0.1094 0.03146000 potential spouse donors could be available. This
46–60 20.0122 0.1040
projection is based on a waiting list composed of 95% .60 20.2260 0.0810
6. Recipient body mass kg/m2adults, 50% of whom are married, 60% of whom have
5–14 20.1804 20.0770an ABO-compatible spouse, and a 50% dropout rate 15–28 0.1066 20.1368
following initial screening for other reasons. If the 6000 .28 0.0738 20.0598
7. Recipient pre-transplant medical statuspotential spouse donors became actual donors, the U.S.
Full work 0.2406 0.1514waiting list could be reduced by 15%, and the number Part work 20.0400 20.0252
Homebound 20.0304 20.1298of available cadaver kidneys would effectively increase
Hospitalized 20.1702 0.0034for those patients who did not have an alternative donor
(continued)source. Clearly, the 1765 total accrued spouse transplants
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